Physician profile
Benjamin Oheim
NPI 1568940708
$7,454.18
in general payments reported to CMS, 2019-2025
27 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 91% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,452 · 2022: $1,506 · 2023: $744 · 2024: $1,447 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,456 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,455.67 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,199.03 | 2021-2024 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $778.61 | 2021-2025 | |
| Novo Nordisk INC | $681.01 | 2022-2025 | Ozempic, Wegovy |
| Impulse Dynamics (USA) INC. | $619.62 | 2021-2024 | Optimizer |
| Atricure, INC. | $556.55 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $411.90 | 2023-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $408.28 | 2021-2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.87 | 2022-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $326.41 | 2021-2024 | Xarelto |
| Abbott Laboratories | $293.28 | 2021-2025 | Aveir, Cardiomems, Gallant |
| Pfizer INC. | $268.95 | 2021-2024 | |
| Cvrx, INC. | $247.14 | 2021-2023 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $217.04 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $204.28 | 2021-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $149.67 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $118.82 | 2024-2025 | Onpattro, Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $114.47 | 2021-2025 | Camzyos |
| Biosense Webster, INC. | $112.31 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $70.98 | 2024 | |
| Vital Connect, INC | $69.21 | 2024-2025 | Vitalpatch Rtm |
| Kiniksa Pharmaceuticals International, Plc | $68.36 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $62.92 | 2023-2024 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $37.10 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $30.85 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, Ltd. | $16.34 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.16 | 2023 | Brilinta |
| Lilly USA, LLC | $14.02 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Oheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.